20 results
8-K
EX-99.1
0fgx9y
29 Sep 22
GB2064 Shows Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis, Validating LOXL2 as a Clinical Fibrosis Target
7:00am
8-K
EX-99.1
tjwhius8 710iy
5 Jan 22
Regulation FD Disclosure
4:02pm
10-K
3n4opmagcs96
29 Mar 21
Annual report
6:03am
8-K
EX-99.1
rel2n2v3
5 Jan 21
Results of Operations and Financial Condition
4:31pm
10-Q
rtrlquk8ri j521uw
11 Dec 20
Quarterly report
7:30am
424B4
rppen5c7ckhfwe7auzxy
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1/A
yd54rv
22 Oct 20
IPO registration (amended)
6:13am
S-1
wmk 3gga0snl
7 Oct 20
IPO registration
5:01pm
DRS
31w2od8 gga5ljirx
2 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next